Should the ANSES proposal be adopted and CBD officially classified as a Category 1B reproductive toxicant, the regulatory implications for every CBD product sold in the European Union would be profound and immediate, triggering a cascade of mandatory compliance measures. First and foremost, all product packaging and containers would be required to display specific hazard pictograms and standardized precautionary statements, including the signal word “Danger” alongside the explicit hazard phrases: “May damage fertility,” “May damage the unborn child,” and “May cause harm to breast-fed children.” These warnings would need to appear conspicuously on every bottle of CBD oil, every packet of gummies, and every carton of CBD-infused beverages, fundamentally altering the marketing appeal of these products from wellness supplements to potentially hazardous substances. Furthermore, the classification would impose strict restrictions on the maximum concentration of CBD allowed in certain product categories, potentially limiting consumer exposure to levels far below those currently on the market. Manufacturers would also face new obligations under workplace safety regulations, requiring them to implement engineering controls, provide personal protective equipment for employees handling raw CBD isolates, and conduct routine health monitoring of workers who might experience occupational exposure. The classification would also trigger reporting requirements under the EU’s Poison Centre Notification framework, meaning that importers would have to submit detailed toxicological dossiers to national poison centers before placing any product on the market. From a litigation perspective, such a classification would expose companies to increased liability risks, as consumers who experienced adverse health outcomes could more easily establish a causal link and claim damages. The industry has vigorously contested the proposal, commissioning its own independent toxicological reviews to challenge the methodology and dose extrapolation used by ANSES.